SCR-LIP-000341 · Claim · machine-readable JSON →
In a Swiss referral cohort of 381 lipedema patients, chronic vascular disease was the dominant comorbidity affecting 86.2% (predominantly chronic venous disease rather than atherosclerosis), and comorbidity burden increased with stage on univariate analysis (OR 1.59, 95% CI 1.39–1.81) but lost independent significance after adjusting for age and BMI in multivariate regression.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Clinical characteristics, comorbidities, and correlation with advanced lipedema stages: A retrospective study from a Swiss referral centre — Luta et al. (2025) ✓ verified — consistent · cohort · 2025 · reading confidence: high
Large retrospective cohort directly reports chronic venous disease as the dominant comorbidity (86.2%) in lipedema patients, bearing on the question of venous disease association; however the comorbidity-stage link lost independence after a
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000018